Author

J. Vicogne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

O. Melnyk· 2 shared A. Mougel· 1 shared B. Leclerc· 1 shared C. Dissous· 1 shared C. Simonneau· 1 shared E. Adriaenssens· 1 shared E. Gherardi· 1 shared F. Forneris· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

O. Melnyk

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Self-Purifying Microfluidic System for Identifying Drugs Acting Against Adult Schistosomes

V. Girod, M.-J. Ghoris, S. Caby, C. Dissous, O. Melnyk, V. Senez, J. Vicogne

This paper introduces a microfluidic system for identifying antischistosomal drugs by selecting healthy adult worms and detecting compound activity through detachment readouts.

bioRxiv · Apr 4, 2022Bioengineering

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist.

G. de Nola, B. Leclerc, A. Mougel, S. Dezitter-Taront, C. Simonneau, F. Forneris, E. Adriaenssens, H. Drobecq, O. Melnyk, E. Gherardi, H. de Jonge, J. Vicogne

This study designs and characterizes K1K1, a minimal MET receptor agonist made from two kringle 1 domains of HGF/SF, showing stability and biological activity comparable to native HGF/SF in vitro and in a mouse liver disease model.

bioRxiv · Jul 20, 2020Bioengineering